Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavannah Resources Regulatory News (SAV)

Share Price Information for Savannah Resources (SAV)

Share Price is delayed by 15 minutes
Get Live Data
6.35    -0.15 (-2.31%)
Bid:
6.20
Ask:
6.50
Spread: 0.30 (4.839%)
Market Cap: £163.54m
SAV Live PriceLast checked at - London Stock Exchange

Intraday Savannah Resources Share Chart

Exercise of Warrants

27 Jun 2018 12:30

RNS Number : 7825S
Savannah Resources PLC
27 June 2018
 

 

27 June 2018

Savannah Resources Plc

Exercise of Warrants

 

Savannah Resources plc (AIM:SAV) ('Savannah') or the 'Company'), the AIM quoted resource development company, announces that it has issued 398,810 new ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at exercise price of 6 pence per (the "New Shares"), following the exercise of warrants.

 

Application will be made for the New Shares, which will rank pari passu with existing Ordinary Shares, to be admitted to trading on AIM ('Admission'). It is expected that Admission will become effective and dealings will commence at 8:00 a.m. on or around 3 July 2018.

 

Total Voting Rights & Regulatory Information

 

Following Admission, the total issued share capital of the Company will consist of 701,615,540 Ordinary Shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

This Announcement contains inside information for the purposes of Article 7 of the Regulation (EU) 596/2014.

 

*ENDS*

 

For further information please visit www.savannahresources.com or contact: 

David Archer

Savannah Resources plc

Tel: +44 20 7117 2489

David Hignell / Dugald J. Carlean (Nominated Adviser)

Northland Capital Partners Ltd

Tel: +44 20 3861 6625

Christopher Raggett / Camille Gochez (Broker)

finnCap Ltd

Tel: +44 20 7220 0500

Grant Barker (Equity Adviser)

Whitman Howard

Tel: +44 020 7659 1225

Charlotte Page / Lottie Wadham (Financial PR)

St Brides Partners Ltd

Tel: +44 20 7236 1177

 

About Savannah

We are a diversified resources group (AIM: SAV) with a portfolio of energy metals projects - lithium in Portugal and copper in Oman - together with the world-class Mutamba Heavy Mineral Sands Project in Mozambique, which is being developed in a consortium with the global major Rio Tinto. We are committed to serving the interests of our shareholders and to delivering outcomes that will improve the lives of our staff and the communities we work with.

 

The group is listed and regulated on AIM and the Company's ordinary shares are also available on the Börse Stuttgart (SWB) under the ticker "SAV".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEEAFKXAAEPEFF
Date   Source Headline
29th Jun 20267:10 amRNSRecommencement of Fieldwork
17th Jun 20267:00 amRNSStakeholder engagement & bypass road update
9th Jun 20264:55 pmRNSLand Access Claim
26th May 20267:00 amRNSExercise of Share Options
21st May 202612:20 pmRNSResult of Annual General Meeting
21st May 20267:00 amRNSAGM Statement
18th May 20267:00 amRNSTechnical work update and first capex purchase
11th May 20267:00 amRNSNotification of Major Shareholding
6th May 202612:30 pmRNSSecond temporary land access granted
1st May 20267:00 amRNSEquity Incentive Plan Awards
21st Apr 20267:00 amRNSInvestor Presentation
17th Apr 20267:00 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSFinancial Results & Notice of AGM
7th Apr 20267:00 amRNSInvestor Presentation
23rd Mar 20267:00 amRNSProject Timetable Update
20th Mar 20267:00 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSProject Update
21st Jan 20267:00 amRNSOfficial signing of the Portuguese State Grant
15th Jan 20267:00 amRNSProject and Market Update
9th Jan 202611:08 amRNSApproval of up to €110m Portuguese State Grant
23rd Dec 20257:00 amRNSChanges To Technical Team
23rd Dec 20257:00 amRNSChanges To Technical Team
19th Dec 20257:00 amRNSAcquisition of Aldeia Mining Lease - Update
19th Dec 20257:00 amRNSAcquisition of Aldeia Mining Lease - Update
12th Dec 20257:00 amRNSRESourceEU Action Plan – Update
4th Dec 20257:00 amRNSReconfirmation of Strategic Project Status
1st Dec 202511:30 amRNS-RSavannah CEO interviewed on Vox Markets
26th Nov 20257:00 amRNSOperational and Sector Update
25th Nov 20257:00 amRNSPurchase of shares by CEO
21st Nov 20257:00 amRNSNotification of Major Shareholding
19th Nov 20257:00 amRNSNotification of Major Shareholding
11th Nov 20253:40 pmRNSResult of RetailBook Offer
11th Nov 20257:00 amRNSInvestor Presentation
7th Nov 20257:40 amRNSInvestor Presentation via Investor Meet Company
7th Nov 20257:26 amRNSResult of Accelerated Bookbuild and Subscription
6th Nov 20255:37 pmRNSRetail Offer
6th Nov 20255:11 pmRNSProposed Fundraise
27th Oct 20257:00 amRNS-RMoU with local healthcare group
23rd Oct 20257:00 amRNSParticipation in trade delegations to Japan
21st Oct 20257:00 amRNSDismissal of Legal Claim
7th Oct 20257:01 amRNSBoard Changes
7th Oct 20257:00 amRNSNotification of Major Shareholding
29th Sep 20257:00 amRNSEquity Incentive Plan – Update
29th Sep 20257:00 amRNSChange of Registered Office
24th Sep 20257:00 amRNSInterim Results for six months ending 30 June 2025
23rd Sep 20258:55 amRNS-RInvestor Presentation
15th Sep 20257:00 amRNSBarroso Lithium Project - JORC Resource Update
4th Sep 20257:04 amRNSProject Update
21st Aug 20257:00 amRNSFinal Assays for Updated Resource Estimates
28th Jul 20257:00 amRNSEquity Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.